These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 29881970)

  • 1. Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations.
    Ngan CL; Asmawi AA
    Drug Deliv Transl Res; 2018 Oct; 8(5):1527-1544. PubMed ID: 29881970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.
    Weber S; Zimmer A; Pardeike J
    Eur J Pharm Biopharm; 2014 Jan; 86(1):7-22. PubMed ID: 24007657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine in pulmonary delivery.
    Mansour HM; Rhee YS; Wu X
    Int J Nanomedicine; 2009; 4():299-319. PubMed ID: 20054434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein and peptide delivery to lungs by using advanced targeted drug delivery.
    Chellappan DK; Prasher P; Saravanan V; Vern Yee VS; Wen Chi WC; Wong JW; Wong JK; Wong JT; Wan W; Chellian J; Molugulu N; Prabu SL; Ibrahim R; Darmarajan T; Candasamy M; Singh PK; Mishra V; Shastri MD; Zacconi FC; Chakraborty A; Mehta M; Gupta PK; Dureja H; Gulati M; Singh SK; Gupta G; Jha NK; George Oliver BG; Dua K
    Chem Biol Interact; 2022 Jan; 351():109706. PubMed ID: 34662570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-based carriers for pulmonary products: preclinical development and case studies in humans.
    Cipolla D; Shekunov B; Blanchard J; Hickey A
    Adv Drug Deliv Rev; 2014 Aug; 75():53-80. PubMed ID: 24819218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary delivery of anti-inflammatory agents.
    Ali ME; McConville JT; Lamprecht A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):929-45. PubMed ID: 25534260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica nanoparticles for pulmonary drug delivery.
    García-Fernández A; Sancenón F; Martínez-Máñez R
    Adv Drug Deliv Rev; 2021 Oct; 177():113953. PubMed ID: 34474094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity screening of emulsifiers for pulmonary application of lipid nanoparticles.
    Steiner V; Öhlinger K; Corzo C; Salar-Behzadi S; Fröhlich E
    Eur J Pharm Sci; 2019 Aug; 136():104968. PubMed ID: 31233864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured lipid carriers for site-specific drug delivery.
    Khosa A; Reddi S; Saha RN
    Biomed Pharmacother; 2018 Jul; 103():598-613. PubMed ID: 29677547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery strategies for sustained drug release in the lungs.
    Loira-Pastoriza C; Todoroff J; Vanbever R
    Adv Drug Deliv Rev; 2014 Aug; 75():81-91. PubMed ID: 24915637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocrystals based pulmonary inhalation delivery system: advance and challenge.
    Yue P; Zhou W; Huang G; Lei F; Chen Y; Ma Z; Chen L; Yang M
    Drug Deliv; 2022 Dec; 29(1):637-651. PubMed ID: 35188021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled lipid nanocarriers for pulmonary delivery of glucocorticoids: Previous strategies, recent advances and key factors description.
    Altube MJ; Perez N; Romero EL; Morilla MJ; Higa LH; Perez AP
    Int J Pharm; 2023 Jul; 642():123146. PubMed ID: 37330156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary drug delivery: a role for polymeric nanoparticles?
    d'Angelo I; Conte C; Miro A; Quaglia F; Ungaro F
    Curr Top Med Chem; 2015; 15(4):386-400. PubMed ID: 25579350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
    Dua K; Bebawy M; Awasthi R; Tekade RK; Tekade M; Gupta G; De Jesus Andreoli Pinto T; Hansbro PM
    Pharm Nanotechnol; 2017; 5(4):243-249. PubMed ID: 28786352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based carriers: manufacturing and applications for pulmonary route.
    Jaafar-Maalej C; Elaissari A; Fessi H
    Expert Opin Drug Deliv; 2012 Sep; 9(9):1111-27. PubMed ID: 22724618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-inside-micro: Disease-responsive microgels with encapsulated nanoparticles for intracellular drug delivery to the deep lung.
    Wanakule P; Liu GW; Fleury AT; Roy K
    J Control Release; 2012 Sep; 162(2):429-37. PubMed ID: 22841795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
    Muntimadugu E; Dhommati R; Jain A; Challa VG; Shaheen M; Khan W
    Eur J Pharm Sci; 2016 Sep; 92():224-34. PubMed ID: 27185298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation.
    Zhao Y; Chang YX; Hu X; Liu CY; Quan LH; Liao YH
    Int J Pharm; 2017 Jan; 516(1-2):364-371. PubMed ID: 27884712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of solid lipid nanoparticles for sustained drug release.
    Attama AA; Umeyor CE
    Ther Deliv; 2015; 6(6):669-84. PubMed ID: 26149784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.